| - GRCh37:
- Chr9:80921276
- GRCh38:
- Chr9:78306360
| PSAT1 | Y148* | PSAT deficiency | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80921446
- GRCh38:
- Chr9:78306530
| PSAT1 | | PSAT deficiency, not provided, Neu-Laxova syndrome 2
| Benign (Oct 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80932574
- GRCh38:
- Chr9:78317658
| PSAT1 | | PSAT deficiency, Neu-Laxova syndrome 2, not provided
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80923436
- GRCh38:
- Chr9:78308520
| PSAT1 | S226L | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Feb 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80932644
- GRCh38:
- Chr9:78317728
| PSAT1 | A265T | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Mar 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80943046-80943047
- GRCh38:
- Chr9:78328130-78328131
| PSAT1 | R319fs | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Nov 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr9:80921252
- GRCh38:
- Chr9:78306336
| PSAT1 | W140C | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Nov 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr9:80923465
- GRCh38:
- Chr9:78308549
| PSAT1 | N236H | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Jun 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80912101
- GRCh38:
- Chr9:78297185
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944941
- GRCh38:
- Chr9:78330025
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944721
- GRCh38:
- Chr9:78329805
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80923459
- GRCh38:
- Chr9:78308543
| PSAT1 | A234S | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80923424
- GRCh38:
- Chr9:78308508
| PSAT1 | R222Q | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80921331
- GRCh38:
- Chr9:78306415
| PSAT1 | D167N | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80921277
- GRCh38:
- Chr9:78306361
| PSAT1 | V149M | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80921223
- GRCh38:
- Chr9:78306307
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80919829
- GRCh38:
- Chr9:78304913
| PSAT1 | V124I | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80944556
- GRCh38:
- Chr9:78329640
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944500
- GRCh38:
- Chr9:78329584
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944498
- GRCh38:
- Chr9:78329582
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80919794
- GRCh38:
- Chr9:78304878
| PSAT1 | A112V | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Jun 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80919729
- GRCh38:
- Chr9:78304813
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80919690
- GRCh38:
- Chr9:78304774
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Aug 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80915564
- GRCh38:
- Chr9:78300648
| PSAT1 | G36D | PSAT deficiency | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944380
- GRCh38:
- Chr9:78329464
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944295
- GRCh38:
- Chr9:78329379
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944254
- GRCh38:
- Chr9:78329338
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944253
- GRCh38:
- Chr9:78329337
| PSAT1 | | PSAT deficiency | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944221
- GRCh38:
- Chr9:78329305
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80943963
- GRCh38:
- Chr9:78329047
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Aug 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80915561
- GRCh38:
- Chr9:78300645
| PSAT1 | V35D | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80912136
- GRCh38:
- Chr9:78297220
| PSAT1 | P4A | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80912130
- GRCh38:
- Chr9:78297214
| PSAT1 | D2Y | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Nov 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80915583
- GRCh38:
- Chr9:78300667
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Oct 15, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80944000
- GRCh38:
- Chr9:78329084
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency, not provided
| Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80915516
- GRCh38:
- Chr9:78300600
| PSAT1 | | PSAT deficiency | Uncertain significance (Nov 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80943013
- GRCh38:
- Chr9:78328097
| PSAT1 | R306C | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80912170
- GRCh38:
- Chr9:78297254
| PSAT1 | A15V | not provided | Uncertain significance (Jul 3, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80921264
- GRCh38:
- Chr9:78306348
| PSAT1 | D145fs | not provided | Pathogenic (Jul 3, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944867
- GRCh38:
- Chr9:78329951
| PSAT1 | | PSAT deficiency | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944838
- GRCh38:
- Chr9:78329922
| PSAT1 | | not provided, PSAT deficiency | Conflicting interpretations of pathogenicity (Jun 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80944791
- GRCh38:
- Chr9:78329875
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944672
- GRCh38:
- Chr9:78329756
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944666
- GRCh38:
- Chr9:78329750
| PSAT1 | | PSAT deficiency | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944594
- GRCh38:
- Chr9:78329678
| PSAT1 | | PSAT deficiency | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944424
- GRCh38:
- Chr9:78329508
| PSAT1 | | PSAT deficiency | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944254
- GRCh38:
- Chr9:78329338
| PSAT1 | | PSAT deficiency | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80944243
- GRCh38:
- Chr9:78329327
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80943948
- GRCh38:
- Chr9:78329032
| PSAT1 | | PSAT deficiency, Neu-Laxova syndrome 2 | Benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80943886
- GRCh38:
- Chr9:78328970
| PSAT1 | | PSAT deficiency, Neu-Laxova syndrome 2 | Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80943117
- GRCh38:
- Chr9:78328201
| PSAT1 | | PSAT deficiency, Neu-Laxova syndrome 2 | Conflicting interpretations of pathogenicity (Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80932672
- GRCh38:
- Chr9:78317756
| PSAT1 | K274T | PSAT deficiency | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80923321-80923322
- GRCh38:
- Chr9:78308405-78308406
| PSAT1 | | PSAT deficiency, Neu-Laxova syndrome 2 | Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80921216
- GRCh38:
- Chr9:78306300
| PSAT1 | | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80919826
- GRCh38:
- Chr9:78304910
| PSAT1 | I123V | Neu-Laxova syndrome 2, PSAT deficiency | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80919756
- GRCh38:
- Chr9:78304840
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80912181
- GRCh38:
- Chr9:78297265
| PSAT1 | H19D | PSAT deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr9:80912180
- GRCh38:
- Chr9:78297264
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Conflicting interpretations of pathogenicity (Apr 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:80912169
- GRCh38:
- Chr9:78297253
| PSAT1 | A15P | Neu-Laxova syndrome 2, PSAT deficiency | Uncertain significance (Jul 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80912115
- GRCh38:
- Chr9:78297199
| PSAT1 | | Neu-Laxova syndrome 2, PSAT deficiency | Benign (Oct 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80919758
- GRCh38:
- Chr9:78304842
| PSAT1 | D100A | not provided, PSAT deficiency | Pathogenic/Likely pathogenic (May 1, 2007) | no assertion criteria provided |
| - GRCh37:
- Chr9:80915563
- GRCh38:
- Chr9:78300647
| PSAT1 | G36fs | PSAT deficiency | Pathogenic (May 1, 2007) | no assertion criteria provided |